Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Thioredoxin system activation is associated with the progression of experimental pulmonary arterial hypertension

Published:2021-11 Issue: Volume:284 Page:119917
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Zimmer Alexsandra,Teixeira Rayane Brinck,Constantin Rosalia Lempk,Fernandes-Piedras Tânia Regina Gatelli,Campos-Carraro Cristina,Türck Patrick,Visioli Fernanda,Baldo Guilherme,Schenkel Paulo Cavalheiro,Araujo Alex Sander,Belló-Klein Adriane

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Advances in medical therapy for pulmonary arterial hypertension;Sisniega;Curr. Opin. Cardiol.,2019

2. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives;Humbert;Eur. Respir. J.,2019

3. Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-?B signaling pathways;Yan;Pulm. Circ.,2019

4. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats;Wang;Can. J. Physiol. Pharmacol.,2012

5. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats;Xu;Int. J. Med. Sci.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application;Oxidative Medicine and Cellular Longevity;2022-06-06

2. Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension;Frontiers in Medicine;2022-05-12

3. Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels;Frontiers in Pharmacology;2021-12-20

4. Uma Nova Alternativa Terapêutica para o Tratamento da Hipertensão Pulmonar?;Arquivos Brasileiros de Cardiologia;2021-11-22